The global market for GLP-1 receptor agonists is witnessing a surge in demand due to their efficacy in managing type 2 diabetes. Several pharmaceutical companies have secured FDA approval to produce these life-changing medications. {Novo Nordisk|Ascensia Pharmaare a leading producer of GLP-1 receptor agonists, with highly regarded products like